相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction
Siu-Ying Lau et al.
EMERGING MICROBES & INFECTIONS (2020)
Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody
Kristina L. Prachanronarong et al.
JOURNAL OF VIROLOGY (2019)
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
Kristen E. Pascal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Broadly Neutralizing Influenza Hemagglutinin Stem-Specific Antibody CR8020 Targets Residues that Are Prone to Escape due to Host Selection Pressure
Kannan Tharakaraman et al.
CELL HOST & MICROBE (2014)
A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum
Nathan C. Shaner et al.
NATURE METHODS (2013)
Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines
Michael A. Whitt
JOURNAL OF VIROLOGICAL METHODS (2010)
Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein
S Fukushi et al.
JOURNAL OF GENERAL VIROLOGY (2005)
分享论文
